RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 111 filers reported holding RECRO PHARMA INC in Q4 2019. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $32,000 | 0.0% | 11,295 | +0.3% | 0.00% | – |
Q4 2020 | $32,000 | +33.3% | 11,265 | -2.8% | 0.00% | – |
Q3 2020 | $24,000 | -55.6% | 11,588 | -2.2% | 0.00% | – |
Q2 2020 | $54,000 | -43.2% | 11,851 | +2.0% | 0.00% | -100.0% |
Q1 2020 | $95,000 | -57.8% | 11,619 | -5.5% | 0.00% | 0.0% |
Q4 2019 | $225,000 | +66.7% | 12,291 | +0.5% | 0.00% | 0.0% |
Q3 2019 | $135,000 | +8.9% | 12,229 | +0.4% | 0.00% | – |
Q2 2019 | $124,000 | +82.4% | 12,179 | +4.5% | 0.00% | – |
Q1 2019 | $68,000 | -17.1% | 11,654 | +0.4% | 0.00% | – |
Q4 2018 | $82,000 | -1.2% | 11,606 | -0.8% | 0.00% | – |
Q3 2018 | $83,000 | +45.6% | 11,694 | +2.9% | 0.00% | – |
Q2 2018 | $57,000 | -40.6% | 11,367 | +30.5% | 0.00% | – |
Q1 2018 | $96,000 | +12.9% | 8,708 | -5.1% | 0.00% | – |
Q4 2017 | $85,000 | +3.7% | 9,177 | +0.5% | 0.00% | – |
Q3 2017 | $82,000 | +39.0% | 9,133 | +8.1% | 0.00% | – |
Q2 2017 | $59,000 | – | 8,450 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |